The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 104 participants.
Also called NCT06311019
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 104 participants
- Sponsor
- Registry
-
NCT06311019
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06311019. Randomized; no masking; primary purpose treatment. Start 2024-02-27 (actual); primary completion 2025-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections
- Acronym
- Dia2tech
- Condition
- Type 2 Diabetes Treated With Insulin
- Intervention (Device)
- Continuous glucose monitoring and use of connected insulinpen for bolus insulin
- Lead sponsor
- Klavs Würgler Hansen
- Collaborator
- Aarhus University Hospital
Record details
- Record id
cardio:ct-nct06311019- Content hash
19885529f7afd0dda23dc5ed8eb46472d9116a1a4c2ed4382febf894d715037a